Title: Skeletal Muscle Microenvironment Selective Sol–Gel Irreversibility of ROS-responsive Injectable and Conductive Hydrogel for Suppressing Muscle Atrophy A musculoskeletal disease-associated irreversible phase change [Sol (4°C)-Gel (37°C...

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=T17545900
충주 : 국립한국교통대학교 일반대학원, 2026
학위논문(석사) -- 국립한국교통대학교 일반대학원 , 교통에너지융합학과 교통에너지융합학 전공 , 2026. 8
2026
영어
충청북도
x, 68 p. ; 26 cm
지도교수: 박성영
I804:43010-200001026183
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
Title: Skeletal Muscle Microenvironment Selective Sol–Gel Irreversibility of ROS-responsive Injectable and Conductive Hydrogel for Suppressing Muscle Atrophy A musculoskeletal disease-associated irreversible phase change [Sol (4°C)-Gel (37°C...
Title: Skeletal Muscle Microenvironment Selective Sol–Gel Irreversibility of ROS-responsive Injectable and Conductive Hydrogel for Suppressing Muscle Atrophy A musculoskeletal disease-associated irreversible phase change [Sol (4°C)-Gel (37°C)-Gel (4°C)] against reversible [Sol (4°C)-Gel (37°C)-Sol (4°C)] phase transition in normal condition forms the basis for an injectable reactive oxygen species (ROS)-scavenging hydrogel (MnO2@PD-HGC) using MnO2-incorporated polymer dots (MnO2@PD) embedded into hexanoyl glycol chitosan (HGC). The disease-microenvironment-responsive injectable and conductive hydrogel influences the promotion of functional muscle recovery via the cleavage of MnO2 in the presence of ROS inducing an imbalance of hydrophobic interactions to generate the naked-eye detectable irreversible gelation of MnO2@PD-HGC. The cleavage of MnO2 in sarcopenia-microenvironment impacts the resistance of MnO2@PD-HGC (ΔR increases by 184% from 0 to 12 h at 37oC) owing to the formation of Mn2+ alongside the regain of fluorescence via alleviation of FRET. Additionally, analysis with dexamethasone-induced inflammation of C2C12 in a muscle atrophy model highlights the role of sarcopenia- microenvironment sensitive irreversible phase change-based MnO2@PD-HGC hydrogel in scavenging ROS and suppressing sarcopenia via the downregulation of muscle degrading proteins Atrogin-1 and MuRF-1. Finally, in vivo analysis with sarcopenia-induced mice demonstrates the therapeutic capability of MnO2@PD-HGC in influencing skeletal muscle regeneration with an increase in muscle fiber size alongside the real-time wireless response illustrating its ability as a cutting-edge therapeutic and monitoring platform.
목차 (Table of Contents)